+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2024 Moldova Blood Typing, Grouping and Infectious Disease NAT Screening Market - Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays

  • PDF Icon

    Report

  • May 2024
  • Region: Moldova
  • VPG Market Research
  • ID: 5712669
This unique report provides information and analysis not available from any other published source.

The database provides the 2023 supplier shares and strategies, the 2023-2028 volume and sales forecasts for over 40 immunohematology and NAT assays, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including:

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.

The companies analyzed in the report include:

  • Abbott
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Diagast
  • DiaSorin
  • Fujirebio
  • Grifols
  • Hologic
  • Immucor
  • LabCorp
  • Proteome Sciences
  • Quest Diagnostics
  • QuidelOrtho
  • Roche
  • Siemens Healthineers
  • Tecan
  • Thermo Fisher